Cheap nanoparticles stimulate immune response to cancer in the lab

Wednesday, January 29, 2020
(Funded by the National Science Foundation and the National Institutes of Health)

Researchers at the University of Wisconsin–Madison have developed nanoparticles that, in the lab, can activate immune responses to cancer cells. If they are shown to work as well in the body as they do in the lab, the nanoparticles might provide an effective and more affordable way to fight cancer. They are cheaper to produce and easier to engineer than the antibodies that underlie current immunotherapies, which, as drugs, cost tens of thousands of dollars a month.